SearchSearch results for: “”

Stibbe assisted Transics, one of the largest European players in relation to on-board computers and fleet management solutions for the transport and logistics sector, in its IPO on Euronext Brussels.

Stibbe assisted Punch International and Accentis with the 245 million EUR purchase of Punch's real property and the subsequent public offer on all shares of Accentis with the focus on semi-industrial property.

Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.

Stibbe advised a prominent international manufacturer of automated logistics and handling systems on the structuring and incorporation of its Chinese sales company in Hong Kong and Shanghai.

Stibbe advised the underwriters on the EUR 205.7 million capital increase of Xior.

Stibbe advised Euronext Brussels’ listed Tessenderlo Chemie NV on its proposed business combination with its reference shareholder Picanol NV.

Stibbe advised Kempen & Co, Degroof Corporate Finance, Bank Degroof and ING on the private offering by NSI N.V. of 35% of its shares in Intervest Offices & Warehouses NV to a broad group of institutional and qualified investors.

Stibbe advised Tessenderlo Group on the issuance and public offering of bonds to retail investors for the amount of EUR 250 million.

Stibbe advised Euronext Brussels’ listed Tessenderlo Chemie NV on its EUR 175 million rights’ offering and capital increase, backed by its reference shareholder Picanol NV.

Stibbe assisted Syngenta Crop Protection AG in its successful public voluntary take-over bid on all outstanding securities of Devgen NV.

Stibbe assisted a leading Belgian bank with a number of highly complex and sensitive litigation cases about the sale of Collateralized Debt Obligations (CDOs) to corporate and private clients during the period 2005-2007.

Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.